Atom Investors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Atom Investors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,309,331	Closed	-$14.9M	–	333
2020 Q4	$14.9M	Buy	1,309,331 +103,387	+9%	+$1.13M	1.51%	10
2020 Q3	$10.8M	Buy	1,205,944 +150,307	+14%	+$1.49M	1.03%	22
2020 Q2	$10.9M	Sell	1,055,637 -41,595	-4%	-$426K	0.71%	17
2020 Q1	$11.1M	Buy	1,097,232 +743,870	+211%	+$8.74M	0.97%	26
2019 Q4	$4.7M	Sell	353,362 -333,592	-49%	-$3.68M	0.38%	80
2019 Q3	$5.9M	Buy	+686,954	New	+$6.68M	0.4%	88
2019 Q2	–	Sell	-152,073	Closed	-$1.72M	–	512
2019 Q1	$1.72M	Sell	152,073 -45,353	-23%	-$507K	0.15%	142
2018 Q4	$1.71M	Buy	+197,426	New	+$2.27M	0.17%	128

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Atom Investors's IRWD Position: Q1 2021 in Review

Atom Investors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2021, closing a stake of 1,309,331 shares — an estimated $14.9M sold.

Atom Investors first reported a position in IRWD in Q4 2018 and held it in 8 quarters. The position peaked at $14.9M in Q4 2020. 209 funds tracked by Wall St. Rank hold IRWD as of Q1 2021.

Atom Investors reported no remaining Ironwood Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Atom Investors sold 1,309,331 Ironwood Pharmaceuticals shares in Q1 2021, an estimated $14.9M.
Atom Investors first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 8 quarters.
Atom Investors's Ironwood Pharmaceuticals position peaked at $14.9M in Q4 2020.
209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.